NICOTINE POLACRILEX GUM

NICOTINE POLACRILEX GUM was reported 6259 times

NICOTINE POLACRILEX GUM is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 FINNEGAN SCORE INCREASED 5 0.5000
1 VAGINAL FLATULENCE 83 0.2739
2 CONTACT STOMATITIS 1 0.1111
3 NICOTINE DEPENDENCE 651 0.0836
4 ORAL MUCOSAL DISCOLOURATION 51 0.0768
5 FALLOPIAN TUBE ENLARGEMENT 1 0.0556
6 INFANT IRRITABILITY 5 0.0510
7 FEMALE GENITAL TRACT FISTULA 84 0.0492
8 MACULAR DEGENERATION 567 0.0474
9 CHEMICAL BURN OF ORAL CAVITY 2 0.0455
10 TOBACCO POISONING 4 0.0370
11 SALIVA DISCOLOURATION 12 0.0359
12 TOOTH DISCOLOURATION 101 0.0343
13 CHRONIC SINUSITIS 125 0.0333
14 RADICULOPATHY 83 0.0315
15 PROCTITIS 82 0.0292
16 HICCUPS 238 0.0290
17 GINGIVAL DISCOMFORT 18 0.0272
18 FLOPPY INFANT 5 0.0272
19 ORAL ALLERGY SYNDROME 3 0.0270
20 ORAL DISCOMFORT 332 0.0239
21 SPERM CONCENTRATION ZERO 2 0.0238
22 PARAESTHESIA MUCOSAL 2 0.0215
23 BURN ORAL CAVITY 12 0.0208
24 EXPOSURE TO UNSPECIFIED AGENT 4 0.0204
25 FOREIGN BODY IN MOUTH 2 0.0200
26 GENITAL ATROPHY 3 0.0196
27 PRODUCT AFTER TASTE 18 0.0189
28 BLOOD ARSENIC INCREASED 1 0.0185
29 TONGUE DISCOLOURATION 73 0.0167
30 LIP DISCOLOURATION 21 0.0166
31 INTENTIONAL DRUG MISUSE 333 0.0159
32 TOBACCO ABUSE 8 0.0150
33 ANAESTHESIA ORAL 1 0.0149
34 TONGUE DISCOMFORT 63 0.0148
35 COMPLICATED MIGRAINE 1 0.0141
36 GINGIVAL BLISTER 6 0.0137
37 PRE-EXISTING DISEASE 6 0.0123
38 BLOOD CARBON MONOXIDE INCREASED 1 0.0123
39 TOBACCO WITHDRAWAL SYMPTOMS 2 0.0114
40 PARAESTHESIA ORAL 165 0.0114
41 BURNING SENSATION MUCOSAL 4 0.0113
42 INTRANASAL HYPOAESTHESIA 1 0.0106
43 ALCOHOL TEST FALSE POSITIVE 1 0.0106
44 GASTROINTESTINAL TRACT MUCOSAL DISCOLOURATION 1 0.0104
45 JAW CLICKING 2 0.0094
46 GINGIVAL DISCOLOURATION 5 0.0093
47 LARYNGEAL SQUAMOUS CELL CARCINOMA 1 0.0093
48 GASTRIC PH INCREASED 1 0.0087
49 PHARYNGEAL HYPOAESTHESIA 8 0.0086
50 LARYNX IRRITATION 2 0.0085
51 ACCIDENTAL EXPOSURE TO PRODUCT PACKAGING 2 0.0084
52 DRUG DELIVERY SYSTEM REMOVAL 1 0.0083
53 BRONCHIAL HYPERREACTIVITY 10 0.0083
54 VAGINAL DISCHARGE 83 0.0082
55 GINGIVAL INJURY 2 0.0082
56 INFUSION SITE SCAB 1 0.0081
57 TONGUE ERUPTION 4 0.0080
58 ORAL MUCOSAL ERUPTION 12 0.0078
59 MUCOSAL DISCOLOURATION 5 0.0078
60 GINGIVAL EROSION 2 0.0078
61 CEREBROVASCULAR SPASM 1 0.0076
62 OROPHARYNGEAL PLAQUE 3 0.0074
63 CHEMICAL BURN OF GASTROINTESTINAL TRACT 1 0.0073
64 BUCCAL MUCOSAL ROUGHENING 1 0.0070
65 CARBOHYDRATE ANTIGEN 27.29 INCREASED 1 0.0067
66 GINGIVAL ULCERATION 5 0.0066
67 LIPOSUCTION 1 0.0065
68 DRUG ADMINISTRATION ERROR 199 0.0065
69 ORAL MUCOSAL ERYTHEMA 10 0.0065
70 ORAL CANDIDIASIS 85 0.0064
71 INFECTIVE GLOSSITIS 1 0.0064
72 CAUSTIC INJURY 2 0.0064
73 EXPIRED PRODUCT ADMINISTERED 210 0.0063
74 PHARYNGEAL PARAESTHESIA 10 0.0063
75 NONINFECTIVE SIALOADENITIS 1 0.0063
76 OROPHARYNGEAL BLISTERING 10 0.0061
77 NEONATAL HYPOXIA 5 0.0060
78 CEREBRAL CONGESTION 1 0.0060
79 DECREASED GAIT VELOCITY 1 0.0060
80 GINGIVAL ERYTHEMA 5 0.0058
81 SALIVARY GLAND ENLARGEMENT 3 0.0057
82 TOOTH EROSION 7 0.0057
83 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 97 0.0057
84 SALIVA ALTERED 5 0.0056
85 TONGUE BLISTERING 12 0.0054
86 DENTAL CARIES 59 0.0053
87 THROAT IRRITATION 238 0.0053
88 MOUTH INJURY 8 0.0053
89 EXPIRED DRUG ADMINISTERED 26 0.0052
90 AGITATION NEONATAL 5 0.0052
91 SENSITIVITY OF TEETH 9 0.0052
92 DRUG TOLERANCE INCREASED 4 0.0051
93 GINGIVAL ATROPHY 1 0.0051
94 GLOSSITIS 17 0.0048
95 OROPHARYNGEAL SPASM 2 0.0047
96 ORAL MUCOSAL EXFOLIATION 7 0.0046
97 GENITAL BURNING SENSATION 4 0.0046
98 OESOPHAGEAL PAIN 18 0.0046
99 PROCEDURAL PAIN 125 0.0045
100 NEUTROPENIA NEONATAL 1 0.0045
101 STASIS DERMATITIS 3 0.0044
102 ANGINA BULLOSA HAEMORRHAGICA 1 0.0043
103 GINGIVAL PAIN 33 0.0041
104 EROSIVE DUODENITIS 3 0.0037
105 COATING IN MOUTH 2 0.0037
106 PRODUCT SELECTION ERROR 4 0.0036
107 PRODUCT TASTE ABNORMAL 49 0.0036
108 ATOPY 1 0.0036
109 PRODUCT PACKAGE ASSOCIATED INJURY 8 0.0036
110 RHEUMATOID FACTOR INCREASED 4 0.0036
111 OESOPHAGEAL IRRITATION 2 0.0034
112 ACCIDENTAL EXPOSURE 14 0.0034
113 DRUG EFFECT LESS THAN EXPECTED 49 0.0033
114 BREATH ODOUR 8 0.0033
115 MYXOEDEMA COMA 1 0.0033
116 FREQUENT BOWEL MOVEMENTS 88 0.0033
117 SENSATION OF FOREIGN BODY 27 0.0032
118 DYSPEPSIA 314 0.0032
119 ORAL PAIN 71 0.0032
120 LIPOATROPHY 3 0.0032
121 LOSS OF PROPRIOCEPTION 1 0.0031
122 DYSTHYMIC DISORDER 1 0.0030
123 DRUG EFFECT FASTER THAN EXPECTED 1 0.0030
124 SALIVARY HYPERSECRETION 30 0.0030
125 BENIGN NEOPLASM OF SKIN 1 0.0030
126 TONGUE ULCERATION 10 0.0030
127 ANION GAP DECREASED 1 0.0029
128 PANCREATIC MASS 3 0.0028
129 CHRONIC LEFT VENTRICULAR FAILURE 1 0.0028
130 VENOUS INSUFFICIENCY 2 0.0028
131 PILOERECTION 3 0.0027
132 GENERALISED BULLOUS FIXED DRUG ERUPTION 1 0.0027
133 PELVIC INFLAMMATORY DISEASE 4 0.0027
134 AMPHETAMINES POSITIVE 2 0.0027
135 LIPID METABOLISM DISORDER 1 0.0026
136 GINGIVAL DISORDER 10 0.0026
137 APHTHOUS STOMATITIS 6 0.0026
138 RHEUMATIC DISORDER 5 0.0026
139 CARDIOVASCULAR SYMPTOM 1 0.0026
140 TONGUE HAEMORRHAGE 3 0.0026
141 FOETAL GROWTH RETARDATION 2 0.0026
142 LIP ERYTHEMA 2 0.0025
143 GINGIVAL SWELLING 11 0.0025
144 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 177 0.0025
145 DEVICE COLOUR ISSUE 1 0.0025
146 OEDEMA MOUTH 8 0.0024
147 DRUG WITHDRAWAL HEADACHE 1 0.0024
148 DENTAL DISCOMFORT 2 0.0024
149 HYPERAESTHESIA TEETH 3 0.0024
150 PRODUCT SOLUBILITY ABNORMAL 12 0.0024
151 GASTROINTESTINAL HYPERMOTILITY 1 0.0023
152 GLOSSODYNIA 52 0.0023
153 THERAPEUTIC PRODUCT EFFECT VARIABLE 9 0.0023
154 RETCHING 49 0.0023
155 STOMATITIS 139 0.0023
156 BULIMIA NERVOSA 1 0.0023
157 DIVORCED 1 0.0023
158 HOMELESS 1 0.0022
159 COLITIS 84 0.0022
160 CATARRH 2 0.0022
161 REACTION TO EXCIPIENT 5 0.0022
162 JOINT INSTABILITY 3 0.0021
163 TONGUE INJURY 2 0.0021
164 PRERENAL FAILURE 3 0.0021
165 PRODUCT SHAPE ISSUE 2 0.0021
166 THERMAL BURN 15 0.0021
167 LIP DISORDER 4 0.0021
168 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 425 0.0021
169 TOOTH INJURY 9 0.0021
170 RECTAL HAEMORRHAGE 88 0.0020
171 TOBACCO USER 3 0.0020
172 PHARYNGEAL OEDEMA 31 0.0020
173 INFERTILITY 3 0.0020
174 PRODUCT PHYSICAL CONSISTENCY ISSUE 11 0.0020
175 THERAPEUTIC PRODUCT EFFECT DELAYED 9 0.0020
176 PRODUCT COATING ISSUE 2 0.0020
177 GASTRIC PH DECREASED 2 0.0020
178 LEUKOPLAKIA ORAL 1 0.0019
179 ORAL DISORDER 14 0.0019
180 COLITIS ULCERATIVE 85 0.0019
181 INFUSION RELATED REACTION 125 0.0019
182 OROPHARYNGEAL DISCOMFORT 17 0.0019
183 AUTOSCOPY 1 0.0019
184 THROAT TIGHTNESS 50 0.0018
185 PHARYNGEAL SWELLING 18 0.0018
186 SKIN WRINKLING 5 0.0018
187 TOOTH FRACTURE 20 0.0018
188 PRODUCT COLOUR ISSUE 9 0.0018
189 ORAL PRURITUS 4 0.0017
190 INCORRECT DRUG ADMINISTRATION DURATION 49 0.0017
191 LIP PAIN 5 0.0017
192 CHEMICAL BURN 2 0.0017
193 TOOTHACHE 31 0.0017
194 MORBID THOUGHTS 2 0.0017
195 SCHIZOAFFECTIVE DISORDER 3 0.0017
196 TONGUE DISORDER 12 0.0017
197 CHOKING SENSATION 9 0.0016
198 FOREIGN BODY IN THROAT 5 0.0016
199 PANCREATIC CYST 3 0.0016
200 CHOLINERGIC SYNDROME 1 0.0016
201 MOUTH SWELLING 9 0.0016
202 HAEMATOCHEZIA 86 0.0016
203 APHTHOUS ULCER 12 0.0015
204 TRANSITIONAL CELL CARCINOMA 2 0.0015
205 INCORRECT ROUTE OF DRUG ADMINISTRATION 55 0.0015
206 PRODUCT PACKAGING DIFFICULT TO OPEN 4 0.0015
207 REVERSIBLE CEREBRAL VASOCONSTRICTION SYNDROME 3 0.0015
208 ALLERGIC REACTION TO EXCIPIENT 3 0.0015
209 ENDOMETRITIS 1 0.0015
210 LIP EXFOLIATION 2 0.0015
211 CATARACT NUCLEAR 1 0.0015
212 FOAMING AT MOUTH 3 0.0015
213 LIP BLISTER 4 0.0015
214 DYSGEUSIA 107 0.0014
215 INFUSION SITE INFLAMMATION 1 0.0014
216 BLOOD ELECTROLYTES DECREASED 2 0.0014
217 JARISCH-HERXHEIMER REACTION 1 0.0014
218 ANTIBODY TEST ABNORMAL 1 0.0014
219 DENTAL RESTORATION FAILURE 1 0.0014
220 FOREIGN BODY ASPIRATION 1 0.0014
221 NONINFECTIVE GINGIVITIS 2 0.0014
222 FINGER AMPUTATION 1 0.0014
223 ARTERIAL INJURY 1 0.0013
224 LIMB CRUSHING INJURY 1 0.0013
225 ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD 9 0.0013
226 INCREASED VISCOSITY OF UPPER RESPIRATORY SECRETION 1 0.0013
227 MASTICATION DISORDER 4 0.0013
228 DUODENITIS 4 0.0013
229 URINARY TRACT OBSTRUCTION 3 0.0013
230 HEPATITIS VIRAL 1 0.0012
231 COMPULSIVE SEXUAL BEHAVIOUR 1 0.0012
232 CHEMICAL INJURY 1 0.0012
233 SUFFOCATION FEELING 3 0.0012
234 FOETAL DISORDER 1 0.0012
235 ENERGY INCREASED 7 0.0012
236 WRONG PRODUCT ADMINISTERED 8 0.0012
237 APTYALISM 1 0.0012
238 FLATULENCE 66 0.0012
239 CATHETER SITE PAIN 3 0.0012
240 AXONAL NEUROPATHY 1 0.0011
241 OROPHARYNGEAL PAIN 105 0.0011
242 HYPOAESTHESIA ORAL 17 0.0011
243 DRUG DETOXIFICATION 1 0.0011
244 MUCOSAL EROSION 1 0.0011
245 SOFT TISSUE INFECTION 2 0.0011
246 DRY THROAT 11 0.0011
247 DRUG INEFFECTIVE 1411 0.0011
248 ARTERIAL DISORDER 2 0.0010
249 PHARYNGEAL DISORDER 3 0.0010
250 INFUSION SITE NODULE 1 0.0010
251 IDIOSYNCRATIC DRUG REACTION 1 0.0010
252 ABDOMINAL DISCOMFORT 169 0.0010
253 ANTISOCIAL BEHAVIOUR 1 0.0010
254 METABOLIC ENCEPHALOPATHY 3 0.0010
255 MOUTH ULCERATION 21 0.0010
256 DILATED CARDIOMYOPATHY 1 0.0010
257 BENIGN BREAST NEOPLASM 1 0.0010
258 EYE COLOUR CHANGE 1 0.0010
259 PHARYNGEAL ERYTHEMA 2 0.0009
260 ORTHOPNOEA 3 0.0009
261 EXPOSURE TO TOXIC AGENT 3 0.0009
262 ERUCTATION 18 0.0009
263 PEPTIC ULCER 3 0.0009
264 FEELING JITTERY 17 0.0009
265 NAUSEA 705 0.0009
266 PRODUCT USE COMPLAINT 14 0.0009
267 DRUG EFFECT VARIABLE 1 0.0009
268 PAIN IN JAW 25 0.0009
269 GINGIVAL BLEEDING 12 0.0009
270 EUPHORIC MOOD 9 0.0009
271 LIP ULCERATION 1 0.0009
272 INCISION SITE PAIN 1 0.0009
273 BONE EROSION 3 0.0008
274 LABILE BLOOD PRESSURE 1 0.0008
275 APPLICATION SITE HYPERSENSITIVITY 1 0.0008
276 INFUSION SITE WARMTH 1 0.0008
277 BLADDER DISCOMFORT 1 0.0008
278 JOINT WARMTH 1 0.0008
279 PRODUCT QUALITY ISSUE 109 0.0008
280 ENDODONTIC PROCEDURE 2 0.0008
281 FACIAL PAIN 7 0.0008
282 THERAPEUTIC PRODUCT EFFECT DECREASED 35 0.0008
283 MICROCEPHALY 1 0.0008
284 INCREASED UPPER AIRWAY SECRETION 4 0.0008
285 OBSTRUCTION GASTRIC 1 0.0008
286 COUNTERFEIT PRODUCT ADMINISTERED 1 0.0008
287 APPLICATION SITE PARAESTHESIA 1 0.0008
288 FOREIGN BODY IN RESPIRATORY TRACT 1 0.0008
289 DRUG SCREEN POSITIVE 6 0.0008
290 FEELING GUILTY 1 0.0008
291 AZOTAEMIA 3 0.0008
292 FOREIGN BODY 3 0.0007
293 TEMPOROMANDIBULAR JOINT SYNDROME 2 0.0007
294 PRODUCT PHYSICAL ISSUE 15 0.0007
295 HOMICIDAL IDEATION 3 0.0007
296 CHEILITIS 4 0.0007
297 SWOLLEN TONGUE 23 0.0007
298 SKIN LACERATION 8 0.0007
299 AGORAPHOBIA 1 0.0007
300 NONSPECIFIC REACTION 4 0.0007
301 ACCIDENTAL EXPOSURE TO PRODUCT 75 0.0007
302 TOOTH DISORDER 16 0.0007
303 INJECTION SITE HYPOAESTHESIA 1 0.0007
304 LIP SWELLING 23 0.0007
305 HYPERVENTILATION 4 0.0007
306 DIABETES MELLITUS NON-INSULIN-DEPENDENT 1 0.0007
307 UNDERDOSE 50 0.0007
308 MOUTH HAEMORRHAGE 5 0.0007
309 URINE ODOUR ABNORMAL 4 0.0007
310 INCORRECT DOSE ADMINISTERED 153 0.0007
311 MALAISE 291 0.0007
312 CALCULUS URINARY 1 0.0006
313 MEAN CELL VOLUME DECREASED 1 0.0006
314 BACTERIAL VAGINOSIS 1 0.0006
315 NIGHTMARE 22 0.0006
316 SKIN ABRASION 3 0.0006
317 DRUG EFFECT INCREASED 2 0.0006
318 INTERMITTENT CLAUDICATION 1 0.0006
319 FINGER DEFORMITY 3 0.0006
320 DRY MOUTH 50 0.0006
321 SUBSTANCE ABUSE 5 0.0006
322 DENTAL IMPLANTATION 1 0.0006
323 DRUG WITHDRAWAL SYNDROME NEONATAL 9 0.0006
324 MEAN CELL HAEMOGLOBIN CONCENTRATION DECREASED 1 0.0006
325 DYSLIPIDAEMIA 3 0.0006
326 LOWER RESPIRATORY TRACT CONGESTION 1 0.0006
327 BLOOD PH DECREASED 1 0.0006
328 BLOOD TESTOSTERONE DECREASED 4 0.0006
329 VARICOSE VEIN 3 0.0006
330 TACHYPHRENIA 2 0.0006
331 TONSILLITIS 3 0.0006
332 FORMICATION 4 0.0006
333 INFUSION SITE DISCHARGE 1 0.0006
334 WRONG DRUG ADMINISTERED 5 0.0006
335 PRODUCT SIZE ISSUE 3 0.0006
336 PRODUCT RESIDUE PRESENT 3 0.0006
337 GINGIVITIS 3 0.0006
338 PRURITUS GENERALISED 12 0.0006
339 BLOOD POTASSIUM INCREASED 9 0.0006
340 NERVOUSNESS 28 0.0005
341 HYPERTENSIVE HEART DISEASE 1 0.0005
342 NASAL OBSTRUCTION 1 0.0005
343 BLOOD IRON INCREASED 1 0.0005
344 LACERATION 5 0.0005
345 PRODUCT PACKAGING ISSUE 5 0.0005
346 SKIN ATROPHY 3 0.0005
347 GINGIVAL RECESSION 1 0.0005
348 ERYTHEMA 106 0.0005
349 SKIN WARM 3 0.0005
350 AUTOIMMUNE DISORDER 5 0.0005
351 THERAPEUTIC RESPONSE UNEXPECTED 23 0.0005
352 FEELING OF BODY TEMPERATURE CHANGE 3 0.0005
353 NASAL SEPTUM DEVIATION 1 0.0005
354 HYPOGEUSIA 1 0.0005
355 ABDOMINAL PAIN UPPER 105 0.0005
356 HYPERAEMIA 1 0.0005
357 NASAL DISCOMFORT 4 0.0005
358 CONSTIPATION 110 0.0005
359 EMPYEMA 1 0.0005
360 HYPOPHYSITIS 1 0.0005
361 PALPITATIONS 58 0.0005
362 WEIGHT DECREASED 138 0.0005
363 TENSION 3 0.0005
364 INJECTION SITE NECROSIS 1 0.0005
365 DECUBITUS ULCER 4 0.0005
366 SELF-MEDICATION 2 0.0005
367 RED CELL DISTRIBUTION WIDTH INCREASED 2 0.0005
368 LIVEDO RETICULARIS 1 0.0005
369 HEART RATE INCREASED 47 0.0005
370 BURNING SENSATION 33 0.0005
371 CATHETER SITE ERYTHEMA 1 0.0005
372 BLOOD GLUCOSE INCREASED 88 0.0005
373 EXOPHTHALMOS 1 0.0005
374 FACIAL PALSY 1 0.0005
375 CHOKING 9 0.0005
376 BLOOD CALCIUM INCREASED 4 0.0005
377 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 25 0.0005
378 PRODUCT FORMULATION ISSUE 3 0.0005
379 INFECTIOUS MONONUCLEOSIS 1 0.0004
380 DRUG EFFECT DELAYED 2 0.0004
381 VASCULAR DEVICE INFECTION 2 0.0004
382 ANAEMIA 84 0.0004
383 KOUNIS SYNDROME 1 0.0004
384 HAEMATOCRIT INCREASED 1 0.0004
385 HAEMOGLOBIN INCREASED 2 0.0004
386 BRAIN OPERATION 1 0.0004
387 DEPENDENCE 24 0.0004
388 HYPERSENSITIVITY 81 0.0004
389 APPLICATION SITE RASH 6 0.0004
390 BRAIN NEOPLASM 4 0.0004
391 GASTROOESOPHAGEAL REFLUX DISEASE 35 0.0004
392 DROOLING 3 0.0004
393 ABDOMINAL PAIN 101 0.0004
394 LYMPHOEDEMA 3 0.0004
395 LICHEN PLANUS 1 0.0004
396 APHONIA 6 0.0004
397 PAPULE 3 0.0004
398 FEAR OF INJECTION 3 0.0004
399 PANIC REACTION 3 0.0004
400 VOMITING 192 0.0004
401 APPLICATION SITE BURN 2 0.0004
402 GASTROINTESTINAL SOUNDS ABNORMAL 2 0.0004
403 DEVICE INFUSION ISSUE 1 0.0004
404 TOOTH EXTRACTION 5 0.0004
405 AGEUSIA 10 0.0004
406 HYPERPARATHYROIDISM SECONDARY 1 0.0004
407 ABNORMAL DREAMS 11 0.0004
408 PRODUCT COMPLAINT 10 0.0004
409 EXCORIATION 1 0.0004
410 THIRST 7 0.0004
411 LACTOSE INTOLERANCE 1 0.0004
412 ABNORMAL UTERINE BLEEDING 1 0.0004
413 TRISMUS 2 0.0004
414 PYREXIA 134 0.0004
415 TOOTH LOSS 8 0.0004
416 HEADACHE 241 0.0004
417 HYPOXIC-ISCHAEMIC ENCEPHALOPATHY 1 0.0004
418 PHARYNGOLARYNGEAL PAIN 2 0.0004
419 ALCOHOL ABUSE 1 0.0004
420 ANAESTHETIC COMPLICATION 1 0.0004
421 BRUXISM 2 0.0004
422 GAMBLING DISORDER 1 0.0004
423 SINUS CONGESTION 5 0.0004
424 INCREASED APPETITE 7 0.0004
425 JAW DISORDER 2 0.0004
426 GASTROINTESTINAL PAIN 4 0.0004
427 WITHDRAWAL SYNDROME 15 0.0004
428 DIZZINESS 178 0.0004
429 HEART RATE IRREGULAR 8 0.0004
430 FORCED EXPIRATORY VOLUME DECREASED 1 0.0004
431 DERMATITIS CONTACT 4 0.0004
432 HYPERTONIA 2 0.0003
433 BLOOD MAGNESIUM DECREASED 3 0.0003
434 HERPES VIRUS INFECTION 2 0.0003
435 PRODUCT ADMINISTRATION ERROR 7 0.0003
436 HAEMOTHORAX 1 0.0003
437 METABOLIC DISORDER 2 0.0003
438 NAIL DISORDER 3 0.0003
439 HYPERTRIGLYCERIDAEMIA 2 0.0003
440 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 10 0.0003
441 GRIP STRENGTH DECREASED 3 0.0003
442 GLUCOSE TOLERANCE IMPAIRED 2 0.0003
443 BLOOD PRESSURE INADEQUATELY CONTROLLED 2 0.0003
444 ACNE CYSTIC 1 0.0003
445 LOSS OF EMPLOYMENT 1 0.0003
446 OVERDOSE 71 0.0003
447 RESPIRATORY DEPRESSION 4 0.0003
448 BRAIN DEATH 1 0.0003
449 LYMPHOMA 5 0.0003
450 POISONING 4 0.0003
451 GALACTORRHOEA 2 0.0003
452 HYPERCHOLESTEROLAEMIA 3 0.0003
453 ATELECTASIS 3 0.0003
454 LOOSE TOOTH 1 0.0003
455 CARDIAC FLUTTER 2 0.0003
456 APPLICATION SITE VESICLES 2 0.0003
457 BACTERIAL SEPSIS 1 0.0003
458 COUGH 86 0.0003
459 SOMNAMBULISM 2 0.0003
460 INFUSION SITE HAEMORRHAGE 1 0.0003
461 LISTLESS 1 0.0003
462 ADVERSE REACTION 4 0.0003
463 HIGH DENSITY LIPOPROTEIN DECREASED 1 0.0003
464 IRRITABILITY 18 0.0003
465 QUALITY OF LIFE DECREASED 4 0.0003
466 ULCER HAEMORRHAGE 2 0.0003
467 APPLICATION SITE DRYNESS 1 0.0003
468 HYPERBILIRUBINAEMIA 3 0.0003
469 DEPRESSION SUICIDAL 1 0.0003
470 LOCAL SWELLING 5 0.0003
471 DEFAECATION URGENCY 2 0.0003
472 POOR QUALITY PRODUCT ADMINISTERED 3 0.0003
473 MUSCLE CONTRACTIONS INVOLUNTARY 1 0.0003
474 HANGOVER 1 0.0003
475 INCONTINENCE 3 0.0003
476 LOGORRHOEA 1 0.0003
477 COLD SWEAT 5 0.0003
478 CHEST DISCOMFORT 29 0.0003
479 JAUNDICE CHOLESTATIC 1 0.0003
480 RENAL PAIN 3 0.0003
481 EATING DISORDER 6 0.0003
482 BREAST PAIN 3 0.0003
483 DRUG EFFECT DECREASED 15 0.0003
484 INCORRECT PRODUCT ADMINISTRATION DURATION 6 0.0003
485 BIPOLAR DISORDER 3 0.0003
486 CAROTID ARTERY OCCLUSION 1 0.0003
487 MAJOR DEPRESSION 2 0.0003
488 SUICIDAL IDEATION 25 0.0003
489 BONE LOSS 4 0.0003
490 CHROMATURIA 6 0.0003
491 PAROSMIA 2 0.0003
492 APPLICATION SITE PRURITUS 6 0.0003
493 ECONOMIC PROBLEM 4 0.0003
494 IMPAIRED DRIVING ABILITY 3 0.0003
495 FACE INJURY 1 0.0003
496 SCAB 3 0.0003
497 SLEEP APNOEA SYNDROME 5 0.0003
498 CONJUNCTIVAL HAEMORRHAGE 1 0.0003
499 DEVICE PHYSICAL PROPERTY ISSUE 2 0.0003
500 PAIN 158 0.0003
501 FAECES HARD 1 0.0003
502 OFF LABEL USE 225 0.0003
503 MUSCLE RUPTURE 1 0.0003
504 CARDIOPULMONARY FAILURE 1 0.0003
505 EPIGASTRIC DISCOMFORT 1 0.0003
506 PRODUCT ADMINISTRATION INTERRUPTED 2 0.0003
507 AFFECTIVE DISORDER 2 0.0003
508 NAIL DISCOLOURATION 1 0.0003
509 RENAL CYST 2 0.0003
510 CHOLECYSTITIS 3 0.0003
511 FEELING COLD 7 0.0003
512 EXPOSURE VIA BREAST MILK 1 0.0003
513 OBESITY 4 0.0003
514 HYPERLIPIDAEMIA 3 0.0003
515 OBSESSIVE-COMPULSIVE DISORDER 2 0.0002
516 MIOSIS 2 0.0002
517 BLOOD PRESSURE INCREASED 38 0.0002
518 PANIC ATTACK 9 0.0002
519 ABNORMAL FAECES 2 0.0002
520 MANIA 4 0.0002
521 CHEST PAIN 45 0.0002
522 ANXIETY 69 0.0002
523 PHARYNGITIS 3 0.0002
524 DRUG LEVEL INCREASED 4 0.0002
525 APPLICATION SITE IRRITATION 3 0.0002
526 PSYCHOMOTOR HYPERACTIVITY 4 0.0002
527 EMBOLISM 2 0.0002
528 SKIN DISORDER 8 0.0002
529 RHABDOMYOLYSIS 10 0.0002
530 DYSPHONIA 14 0.0002
531 URTICARIA 40 0.0002
532 INFUSION SITE ERYTHEMA 2 0.0002
533 ALCOHOLISM 1 0.0002
534 IRRITABLE BOWEL SYNDROME 5 0.0002
535 GASTRIC DISORDER 8 0.0002
536 LACRIMATION INCREASED 7 0.0002
537 FAECES DISCOLOURED 5 0.0002
538 DISCOMFORT 14 0.0002
539 MELANOCYTIC NAEVUS 1 0.0002
540 PULMONARY CONGESTION 3 0.0002
541 LIP DRY 2 0.0002
542 IMPAIRED GASTRIC EMPTYING 3 0.0002
543 WHEEZING 13 0.0002
544 DIARRHOEA 139 0.0002
545 SWELLING FACE 14 0.0002
546 ILLNESS 22 0.0002
547 FLANK PAIN 2 0.0002
548 BLOOD PROLACTIN INCREASED 1 0.0002
549 SINUS TACHYCARDIA 3 0.0002
550 MEDICATION RESIDUE PRESENT 1 0.0002
551 ANGINA PECTORIS 6 0.0002
552 SUPRAVENTRICULAR TACHYCARDIA 2 0.0002
553 FEELING ABNORMAL 50 0.0002
554 HORMONE LEVEL ABNORMAL 1 0.0002
555 TREMOR 34 0.0002
556 INCORRECT DOSAGE ADMINISTERED 1 0.0002
557 KIDNEY INFECTION 4 0.0002
558 RASH PRURITIC 11 0.0002
559 EMBEDDED DEVICE 2 0.0002
560 DISORIENTATION 8 0.0002
561 INFLAMMATORY MARKER INCREASED 1 0.0002
562 HAEMORRHAGE INTRACRANIAL 3 0.0002
563 APPLICATION SITE SWELLING 1 0.0002
564 HYPERAMMONAEMIA 1 0.0002
565 GLYCOSYLATED HAEMOGLOBIN INCREASED 5 0.0002
566 KLEBSIELLA INFECTION 1 0.0002
567 LYMPHADENOPATHY 7 0.0002
568 FEEDING DISORDER 4 0.0002
569 DEVICE FAILURE 3 0.0002
570 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 14 0.0002
571 TOOTH ABSCESS 2 0.0002
572 FEELING HOT 12 0.0002
573 NEUTROPHIL COUNT INCREASED 2 0.0002
574 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 1 0.0002
575 THERAPY PARTIAL RESPONDER 3 0.0002
576 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 10 0.0002
577 ABDOMINAL DISTENSION 20 0.0002
578 ACCIDENTAL OVERDOSE 7 0.0002
579 APPLICATION SITE ERYTHEMA 5 0.0002
580 ANHEDONIA 5 0.0002
581 INJECTION SITE DISCOMFORT 2 0.0002
582 FOOD CRAVING 1 0.0002
583 GASTROINTESTINAL DISORDER 17 0.0002
584 ADVERSE DRUG REACTION 17 0.0002
585 ANORECTAL DISCOMFORT 1 0.0002
586 INSOMNIA 50 0.0002
587 IMPAIRED WORK ABILITY 4 0.0002
588 SENSORY DISTURBANCE 3 0.0002
589 DRUG DEPENDENCE 30 0.0002
590 BEHAVIOUR DISORDER 1 0.0002
591 ERYTHEMA OF EYELID 1 0.0002
592 TREATMENT NONCOMPLIANCE 10 0.0002
593 INTESTINAL ISCHAEMIA 1 0.0002
594 APPLICATION SITE PAIN 4 0.0002
595 GASTRIC ULCER HAEMORRHAGE 1 0.0002
596 OBSTRUCTIVE AIRWAYS DISORDER 2 0.0002
597 HEART RATE ABNORMAL 1 0.0002
598 DYSPHAGIA 17 0.0002
599 INTERMENSTRUAL BLEEDING 1 0.0002
600 WOUND 5 0.0002
601 ANGER 6 0.0002
602 NO ADVERSE EVENT 32 0.0002
603 GRANULOCYTOPENIA 1 0.0002
604 NEUROLOGICAL SYMPTOM 1 0.0002
605 INFLAMMATION 9 0.0002
606 EXERCISE TOLERANCE DECREASED 1 0.0002
607 DYSKINESIA 7 0.0002
608 PARAESTHESIA 27 0.0002
609 INTENTIONAL PRODUCT USE ISSUE 15 0.0002
610 HYPERHIDROSIS 22 0.0002
611 HYPERCHLORHYDRIA 1 0.0002
612 PRODUCTIVE COUGH 8 0.0002
613 DISTURBANCE IN ATTENTION 9 0.0002
614 RESTLESSNESS 6 0.0002
615 ADVERSE EVENT 15 0.0002
616 DRUG ABUSER 1 0.0002
617 HEPATIC STEATOSIS 3 0.0002
618 THINKING ABNORMAL 3 0.0002
619 BLISTER 9 0.0002
620 PNEUMONIA ASPIRATION 4 0.0002
621 NASAL DRYNESS 1 0.0002
622 INFUSION SITE SWELLING 1 0.0002
623 GASTRIC ULCER 3 0.0002
624 HAEMATEMESIS 4 0.0002
625 PULMONARY FIBROSIS 3 0.0002
626 INFUSION SITE PAIN 2 0.0002
627 SKIN ULCER 4 0.0002
628 EAR PAIN 3 0.0002
629 HYPERPROLACTINAEMIA 1 0.0002
630 BLOOD PRESSURE SYSTOLIC INCREASED 3 0.0002
631 DRUG SPECIFIC ANTIBODY PRESENT 1 0.0002
632 AMNESIA 10 0.0002
633 ORAL HERPES 3 0.0002
634 BRADYPHRENIA 1 0.0002
635 SKIN DISCOLOURATION 7 0.0002
636 DEPRESSED LEVEL OF CONSCIOUSNESS 6 0.0002
637 APPETITE DISORDER 1 0.0002
638 CARDIAC FAILURE ACUTE 1 0.0001
639 PALLOR 4 0.0001
640 DYSPNOEA 83 0.0001
641 EYE MOVEMENT DISORDER 1 0.0001
642 ENCEPHALITIS 1 0.0001
643 LARGE INTESTINE POLYP 1 0.0001
644 EXTRASYSTOLES 1 0.0001
645 APPLICATION SITE REACTION 1 0.0001
646 PRODUCT ADHESION ISSUE 5 0.0001
647 PRODUCT DISPENSING ERROR 3 0.0001
648 COMPLICATION ASSOCIATED WITH DEVICE 2 0.0001
649 DRUG EFFECT INCOMPLETE 5 0.0001
650 FLUID RETENTION 7 0.0001
651 CRYING 5 0.0001
652 MIGRAINE 13 0.0001
653 ANGIOEDEMA 6 0.0001
654 BLINDNESS TRANSIENT 1 0.0001
655 TACHYCARDIA 12 0.0001
656 PULMONARY MASS 2 0.0001
657 SNEEZING 3 0.0001
658 CORONARY ARTERY DISEASE 4 0.0001
659 DEPRESSION 30 0.0001
660 OSTEOPENIA 2 0.0001
661 HEPATOCELLULAR CARCINOMA 1 0.0001
662 NEPHROLITHIASIS 6 0.0001
663 HIP ARTHROPLASTY 2 0.0001
664 BOWEL MOVEMENT IRREGULARITY 1 0.0001
665 MATERNAL DRUGS AFFECTING FOETUS 1 0.0001
666 DISSOCIATION 1 0.0001
667 THYROID DISORDER 2 0.0001
668 HYPOALBUMINAEMIA 1 0.0001
669 CONDITION AGGRAVATED 39 0.0001
670 BONE DENSITY DECREASED 4 0.0001
671 GASTROINTESTINAL INFLAMMATION 1 0.0001
672 ARTERIAL OCCLUSIVE DISEASE 1 0.0001
673 PNEUMOTHORAX 2 0.0001
674 LOW BIRTH WEIGHT BABY 1 0.0001
675 ULCER 2 0.0001
676 BLOOD DISORDER 1 0.0001
677 MYASTHENIA GRAVIS 1 0.0001
678 MENTAL IMPAIRMENT 3 0.0001
679 MUSCLE DISORDER 1 0.0001
680 AGITATION 9 0.0001
681 LETHARGY 7 0.0001
682 PRODUCT SUBSTITUTION ISSUE 7 0.0001
683 HEMIPLEGIA 1 0.0001
684 LIVE BIRTH 1 0.0001
685 SOMNOLENCE 24 0.0001
686 FACE OEDEMA 2 0.0001
687 CARDIOVASCULAR DISORDER 3 0.0001
688 OSTEOARTHRITIS 5 0.0001
689 SCAR 2 0.0001
690 HYSTERECTOMY 1 0.0001
691 DELIRIUM 4 0.0001
692 SPEECH DISORDER 6 0.0001
693 JOINT STIFFNESS 3 0.0001
694 ACUTE RESPIRATORY DISTRESS SYNDROME 2 0.0001
695 PRURITUS 43 0.0001
696 FOREIGN BODY IN REPRODUCTIVE TRACT 1 0.0001
697 ANAL INCONTINENCE 1 0.0001
698 PNEUMONITIS 3 0.0001
699 END STAGE RENAL DISEASE 2 0.0001
700 VISION BLURRED 15 0.0001
701 INTENTIONAL OVERDOSE 7 0.0001
702 BLOOD THYROID STIMULATING HORMONE INCREASED 1 0.0001
703 IRON DEFICIENCY ANAEMIA 1 0.0001
704 BLOOD GLUCOSE ABNORMAL 2 0.0001
705 BRONCHITIS 8 0.0001
706 HAEMOPTYSIS 3 0.0001
707 MIDDLE INSOMNIA 2 0.0001
708 DYSARTHRIA 4 0.0001
709 ARTERIOSCLEROSIS 1 0.0001
710 ABORTION INDUCED 1 0.0001
711 DYSPNOEA EXERTIONAL 4 0.0001
712 HOT FLUSH 8 0.0001
713 RASH 46 0.0001
714 DECREASED APPETITE 24 0.0001
715 LIVER FUNCTION TEST ABNORMAL 3 0.0001
716 DIZZINESS POSTURAL 1 0.0001
717 MUSCULOSKELETAL STIFFNESS 9 0.0001
718 DRUG WITHDRAWAL SYNDROME 9 0.0001
719 KNEE OPERATION 1 0.0001
720 HOSPICE CARE 1 0.0001
721 DRUG INTERACTION 16 0.0001
722 BLOOD PRESSURE ABNORMAL 2 0.0001
723 BLOOD POTASSIUM DECREASED 3 0.0001
724 CELLULITIS 5 0.0001
725 CONTRAINDICATED PRODUCT ADMINISTERED 3 0.0001
726 SUICIDE ATTEMPT 6 0.0001
727 TASTE DISORDER 2 0.0001
728 VERTIGO 6 0.0001
729 ASTHENIA 37 0.0001
730 WEIGHT INCREASED 22 0.0001
731 MOTOR DYSFUNCTION 1 0.0001
732 INITIAL INSOMNIA 1 0.0001
733 EAR DISCOMFORT 1 0.0001
734 PRODUCT USE IN UNAPPROVED INDICATION 24 0.0001
735 PRODUCT USE ISSUE 18 0.0001
736 HEAD INJURY 3 0.0001
737 HALLUCINATION, VISUAL 2 0.0001
738 DEPRESSED MOOD 5 0.0001
739 MOOD SWINGS 3 0.0001
740 POOR QUALITY SLEEP 2 0.0001
741 DECREASED ACTIVITY 1 0.0001
742 MENTAL DISORDER 4 0.0001
743 OSTEONECROSIS 3 0.0001
744 ASPIRATION 1 0.0001
745 BLOOD GLUCOSE FLUCTUATION 1 0.0001
746 INJECTION SITE NODULE 1 0.0001
747 VIRAL INFECTION 3 0.0001
748 NERVE INJURY 1 0.0001
749 HYPERTENSION 19 0.0001
750 NECK PAIN 5 0.0001
751 MALNUTRITION 1 0.0001
752 HEPATIC ENZYME INCREASED 6 0.0001
753 CHOLECYSTECTOMY 1 0.0001
754 INTERNAL HAEMORRHAGE 1 0.0001
755 MYOCARDITIS 1 0.0001
756 TINNITUS 4 0.0001
757 NEOPLASM 1 0.0001
758 HYPOAESTHESIA 13 0.0001
759 CONFUSIONAL STATE 14 0.0001
760 LOSS OF CONSCIOUSNESS 11 0.0001
761 RASH MACULAR 3 0.0001
762 HYPERKALAEMIA 3 0.0001
763 SWELLING 8 0.0001
764 NASAL CONGESTION 5 0.0001
765 BACTERAEMIA 1 0.0001
766 ACCIDENT 1 0.0001
767 MUSCLE RIGIDITY 1 0.0001
768 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 4 0.0001
769 EMOTIONAL DISTRESS 10 0.0001
770 BURSITIS 1 0.0001
771 ADRENAL INSUFFICIENCY 1 0.0001
772 ILL-DEFINED DISORDER 5 0.0001
773 FIBROMYALGIA 2 0.0001
774 CYTOPENIA 1 0.0001
775 DYSURIA 3 0.0001
776 CARDIOMEGALY 1 0.0001
777 HYPERCALCAEMIA 1 0.0001
778 ABNORMAL WEIGHT GAIN 1 0.0001
779 SEPSIS 9 0.0001
780 CYST 1 0.0001
781 HAIR COLOUR CHANGES 1 0.0001
782 EPISTAXIS 6 0.0001
783 INJECTION SITE DISCOLOURATION 1 0.0001
784 HALLUCINATION 6 0.0001
785 MUSCULAR WEAKNESS 9 0.0001
786 BRAIN OEDEMA 1 0.0001
787 ACNE 6 0.0001
788 ACUTE KIDNEY INJURY 12 0.0001
789 ANAPHYLACTIC SHOCK 2 0.0001
790 UNRESPONSIVE TO STIMULI 2 0.0001
791 RHINORRHOEA 5 0.0001
792 RASH GENERALISED 2 0.0001
793 PHARMACEUTICAL PRODUCT COMPLAINT 2 0.0001
794 NODULE 1 0.0001
795 DEAFNESS 2 0.0001
796 ECZEMA 4 0.0001
797 ABNORMAL BEHAVIOUR 3 0.0001
798 EAR INFECTION 2 0.0001
799 DEHYDRATION 10 0.0001
800 DRY SKIN 10 0.0001
801 MALIGNANT MELANOMA 1 0.0001
802 FEAR 2 0.0001
803 JAUNDICE 2 0.0001
804 EXTRA DOSE ADMINISTERED 3 0.0001
805 PSORIATIC ARTHROPATHY 3 0.0001
806 DRUG TOXICITY 1 0.0001
807 MOOD ALTERED 2 0.0001
808 OSTEOPOROSIS 3 0.0001
809 ANAPHYLACTIC REACTION 4 0.0001
810 MENTAL STATUS CHANGES 2 0.0001
811 HUNGER 1 0.0001
812 MASS 1 0.0001
813 CARPAL TUNNEL SYNDROME 1 0.0001
814 ALOPECIA 14 0.0001
815 BLOOD TEST ABNORMAL 1 0.0001
816 SLEEP DISORDER 5 0.0001
817 CONVULSION 4 0.0001
818 HYPOTENSION 14 0.0001
819 HYPERSOMNIA 2 0.0001
820 INTENTIONAL PRODUCT MISUSE 6 0.0001
821 DYSSTASIA 2 0.0001
822 LABORATORY TEST ABNORMAL 2 0.0001
823 URINARY INCONTINENCE 2 0.0001
824 RESPIRATORY DISORDER 2 0.0001
825 JOINT SWELLING 8 0.0001
826 APHASIA 2 0.0001
827 THERAPEUTIC RESPONSE DECREASED 4 0.0001
828 BLOOD COUNT ABNORMAL 1 0.0001
829 DIABETES MELLITUS 5 0.0001
830 DEVICE RELATED INFECTION 1 0.0001
831 EMOTIONAL DISORDER 2 0.0001
832 LIMB DISCOMFORT 2 0.0001
833 URINARY TRACT INFECTION 11 0.0001
834 RENAL DISORDER 3 0.0001
835 BRAIN FOG 1 0.0001
836 CYANOSIS 1 0.0001
837 OCULAR HYPERAEMIA 3 0.0001
838 RASH ERYTHEMATOUS 3 0.0001
839 METABOLIC ACIDOSIS 2 0.0001
840 MUSCLE TIGHTNESS 1 0.0001
841 BACK DISORDER 1 0.0001
842 BLOOD CREATININE INCREASED 4 0.0001
843 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 11 0.0001
844 MULTIPLE FRACTURES 1 0.0001
845 EYE DISORDER 2 0.0001
846 BACK PAIN 14 0.0001
847 BLOOD PRESSURE DECREASED 4 0.0001
848 DRY EYE 3 0.0001
849 FUNGAL INFECTION 2 0.0001
850 CHILLS 7 0.0001
851 TYPE 2 DIABETES MELLITUS 2 0.0001
852 TRANSIENT ISCHAEMIC ATTACK 2 0.0001
853 FLUSHING 6 0.0001
854 DRUG EXPOSURE DURING PREGNANCY 2 0.0001
855 CIRCULATORY COLLAPSE 1 0.0001
856 HOSPITALISATION 9 0.0001
857 PERIPHERAL SWELLING 9 0.0001
858 HEART RATE DECREASED 2 0.0001
859 INJURY 4 0.0001
860 BLOOD TRIGLYCERIDES INCREASED 1 0.0001
861 LYMPHOCYTE COUNT DECREASED 1 0.0001
862 DIABETES MELLITUS INADEQUATE CONTROL 1 0.0001
863 ISCHAEMIC STROKE 1 0.0001
864 GOUT 1 0.0001
865 COMPLICATION OF DEVICE REMOVAL 1 0.0001
866 OEDEMA 3 0.0001
867 LEUKOCYTOSIS 1 0.0001
868 MUSCLE SPASMS 10 0.0001
869 PAIN IN EXTREMITY 16 0.0001
870 ARTHROPATHY 3 0.0001
871 FATIGUE 42 0.0001
872 EYE SWELLING 2 0.0001
873 FRACTURE 1 0.0001
874 BLOOD URINE PRESENT 1 0.0001
875 CHRONIC KIDNEY DISEASE 4 0.0001
876 PNEUMONIA 17 0.0001
877 ACUTE RESPIRATORY FAILURE 1 0.0001
878 HAEMORRHOIDS 1 0.0001
879 DISABILITY 1 0.0001
880 HAEMATOCRIT DECREASED 1 0.0001
881 PLEURAL EFFUSION 3 0.0000
882 VISUAL IMPAIRMENT 6 0.0000
883 ROAD TRAFFIC ACCIDENT 2 0.0000
884 TOXICITY TO VARIOUS AGENTS 8 0.0000
885 MYALGIA 8 0.0000
886 DEEP VEIN THROMBOSIS 3 0.0000
887 CLOSTRIDIUM DIFFICILE INFECTION 1 0.0000
888 ARTHRALGIA 19 0.0000
889 MATERNAL EXPOSURE DURING PREGNANCY 4 0.0000
890 INJECTION SITE REACTION 3 0.0000
891 MUSCLE TWITCHING 1 0.0000
892 BLOOD CHOLESTEROL INCREASED 2 0.0000
893 PULMONARY EMBOLISM 4 0.0000
894 COMA 2 0.0000
895 CONTUSION 4 0.0000
896 DRUG INTOLERANCE 4 0.0000
897 HYPOGLYCAEMIA 2 0.0000
898 RESPIRATORY FAILURE 3 0.0000
899 NEURALGIA 1 0.0000
900 CEREBRAL INFARCTION 1 0.0000
901 LUNG DISORDER 2 0.0000
902 LIVER INJURY 1 0.0000
903 ENCEPHALOPATHY 1 0.0000
904 MYOCARDIAL INFARCTION 7 0.0000
905 AGGRESSION 2 0.0000
906 ABDOMINAL PAIN LOWER 1 0.0000
907 GASTRIC CANCER 1 0.0000
908 HEPATITIS 1 0.0000
909 EXPOSURE VIA SKIN CONTACT 1 0.0000
910 PSORIASIS 5 0.0000
911 GASTRITIS 1 0.0000
912 FOETAL EXPOSURE DURING PREGNANCY 3 0.0000
913 LIMB INJURY 1 0.0000
914 DRUG ABUSE 3 0.0000
915 MEDICATION ERROR 2 0.0000
916 PANCYTOPENIA 2 0.0000
917 SKIN EXFOLIATION 3 0.0000
918 EYE PAIN 2 0.0000
919 EYE IRRITATION 2 0.0000
920 BLOOD CREATINE PHOSPHOKINASE INCREASED 1 0.0000
921 SEIZURE 4 0.0000
922 GENERAL PHYSICAL HEALTH DETERIORATION 4 0.0000
923 NEEDLE ISSUE 1 0.0000
924 OEDEMA PERIPHERAL 4 0.0000
925 EPILEPSY 1 0.0000
926 GYNAECOMASTIA 1 0.0000
927 EXPOSURE DURING PREGNANCY 2 0.0000
928 NERVOUS SYSTEM DISORDER 1 0.0000
929 NEUROPATHY PERIPHERAL 3 0.0000
930 GAIT DISTURBANCE 6 0.0000
931 HYPOTHYROIDISM 1 0.0000
932 LACTIC ACIDOSIS 1 0.0000
933 ATRIAL FIBRILLATION 3 0.0000
934 IMPAIRED HEALING 1 0.0000
935 FEBRILE NEUTROPENIA 2 0.0000
936 SYNCOPE 3 0.0000
937 NEOPLASM MALIGNANT 2 0.0000
938 EYE PRURITUS 1 0.0000
939 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 1 0.0000
940 MALIGNANT NEOPLASM PROGRESSION 3 0.0000
941 MEMORY IMPAIRMENT 4 0.0000
942 HYPOXIA 1 0.0000
943 SKIN BURNING SENSATION 2 0.0000
944 MOBILITY DECREASED 2 0.0000
945 ELECTROCARDIOGRAM QT PROLONGED 1 0.0000
946 INFECTION 4 0.0000
947 HYPERGLYCAEMIA 1 0.0000
948 FALL 9 0.0000
949 INTESTINAL OBSTRUCTION 1 0.0000
950 UNEVALUABLE EVENT 2 0.0000
951 DEVICE BREAKAGE 1 0.0000
952 BLINDNESS 1 0.0000
953 NEUTROPHIL COUNT DECREASED 1 0.0000
954 LUNG NEOPLASM MALIGNANT 1 0.0000
955 CARDIAC ARREST 2 0.0000
956 COMPLETED SUICIDE 2 0.0000
957 GASTROINTESTINAL HAEMORRHAGE 2 0.0000
958 CARDIO-RESPIRATORY ARREST 1 0.0000
959 CEREBROVASCULAR ACCIDENT 4 0.0000
960 HYPOACUSIS 1 0.0000
961 BALANCE DISORDER 2 0.0000
962 DEVICE DISLOCATION 1 0.0000
963 PRODUCT STORAGE ERROR 2 0.0000
964 NASOPHARYNGITIS 4 0.0000
965 HYPOKALAEMIA 1 0.0000
966 COGNITIVE DISORDER 1 0.0000
967 CARDIAC DISORDER 2 0.0000
968 ARRHYTHMIA 1 0.0000
969 COLORECTAL CANCER 1 0.0000
970 DERMATITIS ATOPIC 1 0.0000
971 BRADYCARDIA 1 0.0000
972 INFLUENZA 2 0.0000
973 HYPONATRAEMIA 1 0.0000
974 ASTHMA 2 0.0000
975 BONE PAIN 1 0.0000
976 PRODUCT DOSE OMISSION ISSUE 5 0.0000
977 DISEASE PROGRESSION 2 0.0000
978 CATARACT 1 0.0000
979 DEVICE DIFFICULT TO USE 1 0.0000
980 INJECTION SITE PRURITUS 1 0.0000
981 NEUTROPENIA 2 0.0000
982 MULTIPLE SCLEROSIS RELAPSE 1 0.0000
983 DEATH 12 0.0000
984 ARTHRITIS 1 0.0000
985 INJECTION SITE BRUISING 1 0.0000
986 INJECTION SITE HAEMORRHAGE 1 0.0000
987 CARDIAC FAILURE 1 0.0000
988 INFLUENZA LIKE ILLNESS 1 0.0000
989 DRUG DOSE OMISSION 2 0.0000
990 INJECTION SITE PAIN 3 0.0000
991 HAEMOGLOBIN DECREASED 1 0.0000
992 HAEMORRHAGE 1 0.0000